No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr8:67036800-67044800 |
Weak transcription |
Pancreas |
Pancrea
|
2 |
chr8:67036800-67044800 |
Weak transcription |
Spleen |
Spleen
|
3 |
chr8:67036800-67046400 |
Enhancers |
NHLF |
lung
|
4 |
chr8:67036800-67047000 |
Enhancers |
NHDF-Ad |
bronchial
|
5 |
chr8:67036800-67047200 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
6 |
chr8:67037200-67042200 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
7 |
chr8:67037400-67042400 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
8 |
chr8:67037600-67041800 |
Weak transcription |
Hela-S3 |
cervix
|
9 |
chr8:67037800-67041800 |
Weak transcription |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
10 |
chr8:67038800-67042600 |
Active TSS |
Fetal Muscle Trunk |
muscle
|
11 |
chr8:67038800-67042600 |
Active TSS |
Right Atrium |
heart
|
12 |
chr8:67038800-67043800 |
Active TSS |
Right Ventricle |
heart
|
13 |
chr8:67039000-67048800 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
14 |
chr8:67039200-67041600 |
Active TSS |
Left Ventricle |
heart
|
15 |
chr8:67039200-67042400 |
Weak transcription |
Primary B cells from peripheral blood |
blood
|
16 |
chr8:67039400-67042400 |
Weak transcription |
GM12878-XiMat |
blood
|
17 |
chr8:67039400-67043600 |
Weak transcription |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
18 |
chr8:67039600-67042400 |
Weak transcription |
Placenta |
Placenta
|
19 |
chr8:67040000-67042600 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|
20 |
chr8:67040200-67042200 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
21 |
chr8:67040200-67042800 |
Enhancers |
NH-A |
brain
|
22 |
chr8:67040200-67043000 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
23 |
chr8:67040200-67043600 |
Enhancers |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
24 |
chr8:67040200-67043600 |
Enhancers |
Osteobl |
bone
|
25 |
chr8:67040200-67045400 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
26 |
chr8:67040200-67050000 |
Enhancers |
Adipose Nuclei |
Adipose
|
27 |
chr8:67040400-67041200 |
Flanking Active TSS |
Skeletal Muscle Male |
skeletal muscle
|
28 |
chr8:67040400-67042800 |
Flanking Active TSS |
Muscle Satellite Cultured Cells |
--
|
29 |
chr8:67040400-67043000 |
Enhancers |
NHEK |
skin
|
30 |
chr8:67040400-67046400 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
31 |
chr8:67040600-67042800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
32 |
chr8:67040600-67043000 |
Enhancers |
HMEC |
breast
|
33 |
chr8:67040800-67041200 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
34 |
chr8:67040800-67041600 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
35 |
chr8:67040800-67041600 |
Transcr. at gene 5' and 3' |
HSMM |
muscle
|
36 |
chr8:67040800-67041800 |
Active TSS |
HSMMtube |
muscle
|
37 |
chr8:67040800-67042200 |
Flanking Active TSS |
Liver |
Liver
|
38 |
chr8:67040800-67042400 |
Active TSS |
Fetal Muscle Leg |
muscle
|
39 |
chr8:67040800-67044800 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
40 |
chr8:67041000-67041400 |
Enhancers |
Monocytes-CD14+_RO01746 |
blood
|
41 |
chr8:67041000-67041600 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
42 |
chr8:67041000-67041600 |
Enhancers |
Psoas Muscle |
Psoas
|
43 |
chr8:67041000-67041800 |
Weak transcription |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
44 |
chr8:67041000-67042000 |
Active TSS |
Fetal Heart |
heart
|
45 |
chr8:67041000-67042000 |
Active TSS |
Skeletal Muscle Female |
skeletal muscle
|
46 |
chr8:67041000-67042000 |
Enhancers |
A549 |
lung
|
47 |
chr8:67041000-67046200 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|